1. Home
  2. ABCL vs HPP Comparison

ABCL vs HPP Comparison

Compare ABCL & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • HPP
  • Stock Information
  • Founded
  • ABCL 2012
  • HPP 1997
  • Country
  • ABCL Canada
  • HPP United States
  • Employees
  • ABCL N/A
  • HPP N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • HPP Real Estate
  • Sector
  • ABCL Health Care
  • HPP Finance
  • Exchange
  • ABCL Nasdaq
  • HPP Nasdaq
  • Market Cap
  • ABCL 1.1B
  • HPP 1.0B
  • IPO Year
  • ABCL 2020
  • HPP 2010
  • Fundamental
  • Price
  • ABCL $4.55
  • HPP $2.98
  • Analyst Decision
  • ABCL Strong Buy
  • HPP Hold
  • Analyst Count
  • ABCL 5
  • HPP 9
  • Target Price
  • ABCL $8.00
  • HPP $2.96
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • HPP 6.9M
  • Earning Date
  • ABCL 11-03-2025
  • HPP 11-11-2025
  • Dividend Yield
  • ABCL N/A
  • HPP N/A
  • EPS Growth
  • ABCL N/A
  • HPP N/A
  • EPS
  • ABCL N/A
  • HPP N/A
  • Revenue
  • ABCL $32,875,999.00
  • HPP $792,977,000.00
  • Revenue This Year
  • ABCL $15.60
  • HPP N/A
  • Revenue Next Year
  • ABCL $65.70
  • HPP $1.20
  • P/E Ratio
  • ABCL N/A
  • HPP N/A
  • Revenue Growth
  • ABCL N/A
  • HPP N/A
  • 52 Week Low
  • ABCL $1.89
  • HPP $1.78
  • 52 Week High
  • ABCL $5.82
  • HPP $5.56
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 57.55
  • HPP 63.01
  • Support Level
  • ABCL $4.09
  • HPP $2.87
  • Resistance Level
  • ABCL $4.28
  • HPP $2.99
  • Average True Range (ATR)
  • ABCL 0.24
  • HPP 0.12
  • MACD
  • ABCL 0.03
  • HPP 0.01
  • Stochastic Oscillator
  • ABCL 82.76
  • HPP 73.91

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: